Modulating response to genotoxic stress
First Claim
1. A method of modifying sensitivity to genotoxic stress in a cell, comprising exposing the cell to a biological macromolecule that alters phosphorylation of BRCA1 by Cds1 at one or more BRCA1 amino acid residues that affect a cellular response to genotoxic stress.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods are disclosed to modify cellular sensitivity to genotoxic stress by introducing into a cell a biological macromolecule that alters phosphorylation of BRCA1 by Cds1. Such biological macromolecules may be used to enhance genotoxin-induced cell death, or alter genotoxin-induced gene expression. Alternatively, such biological macromolecules may be used to enhance cell survival following exposure to genotoxic agents. Methods are also disclosed for determining exposure to genotoxic stress by assessing the phosphorylation status of BRCA1, for example by using antibody molecules disclosed herein.
-
Citations
63 Claims
- 1. A method of modifying sensitivity to genotoxic stress in a cell, comprising exposing the cell to a biological macromolecule that alters phosphorylation of BRCA1 by Cds1 at one or more BRCA1 amino acid residues that affect a cellular response to genotoxic stress.
-
37. A method of modulating expression from a nucleic acid sequence that is modulated by BRCA1 in a cell, comprising introducing into the cell a nucleic acid encoding BRCA1 or a functional fragment or variant thereof, wherein the nucleic acid comprises a mutation that encodes an amino acid substitution that alters Cds1 phosphorylation of BRCA1.
-
57. A BRCA1 peptide-specific antibody, wherein the BRCA1 peptide comprises a phosphorylated serine residue at a position corresponding to amino acid residue 988 of a human BRCA1 polypeptide.
-
60. A BRCA1 peptide-specific antibody, wherein the BRCA1 peptide comprises an amino acid residue other than serine at a position corresponding to 988 of a human BRCA1 polypeptide.
-
62. A method of determining exposure to genotoxic stress, comprising determining whether S988 of BRCA1 in a cell is phosphorylated.
Specification